Biotechnology for Health and Disease

Development to Cancer Post-test

The same twenty questions you started with, in the same order of ideas. This is where you find out what changed.

You will get your score, four results by idea, and the reasoning for every question.

What this measures and who sees what

Not collecting

This assessment is a reviewable candidate. It is not collecting responses. The district privacy review, the human-subjects determination, and the consent decision come first.

You can read and answer every question here to see what the form is like. Nothing is recorded.

Used once to check you are on the class list. It is not saved in this browser and never appears in the web address.

0 of 20 answered

  1. Question 1 of 20

    Two skin cells contain the same pigment gene, but only one cell makes the pigment protein. Which explanation is best?

  2. Question 2 of 20

    Two developing palates fail to fuse and look similar. In one, a signal is missing. In the other, cells cannot respond to the signal. What follows?

  3. Question 3 of 20

    Cells already committed to cartilage stop migrating when Signal X is removed. A different motility signal restores migration, and the cells still become cartilage. What role did Signal X most likely play?

  4. Question 4 of 20

    A cell still contains a working growth-brake gene, but regulatory proteins keep the gene silent. Which statement is most accurate?

  5. Question 5 of 20

    One cell line activates a growth pathway. Another loses a stop signal. Both divide too often. Which principle fits best?

  6. Question 6 of 20

    What is differentiation?

  7. Question 7 of 20

    During normal development, cells between forming fingers undergo programmed death. What does this show?

  8. Question 8 of 20

    Tumor cells reduce adhesion and move through a remodeled extracellular matrix into nearby tissue. What does this evidence support?

  9. Question 9 of 20

    The same signal promotes cell division early in development but promotes differentiation later. Which explanation is best?

  10. Question 10 of 20

    Which description best defines cancer?

  11. Question 11 of 20

    A biopsy shows abnormal cells crossing into nearby tissue. No distant sites were tested. Which conclusion stays within the evidence?

  12. Question 12 of 20

    A targeted drug kills most cells in a tumor, but a small cell group lacks the target and survives. What is the best prediction?

  13. Question 13 of 20

    A gene-silencing experiment measures tumor-cell growth. Why include cells given a non-targeting RNA?

  14. Question 14 of 20

    Only one culture plate shows sudden cloudy growth, including its control wells. What is the best next step?

  15. Question 15 of 20

    Drug Y reduces growth from 0 to 10 micromolar, then harms normal cells above 10 micromolar. What should researchers compare next?

  16. Question 16 of 20

    Edited cells show the intended DNA change and an unexpected change at a second site. What must the report say?

  17. Question 17 of 20

    A zebrafish mutation changes neural crest migration. Which follow-up best strengthens relevance to humans?

  18. Question 18 of 20

    A result appears only when one analyst uses an undocumented spreadsheet step. What is the main concern?

  19. Question 19 of 20

    A team wants to publish student-level cancer-learning data from minors. What is the correct sequence?

  20. Question 20 of 20

    A combination blocks a growth signal and a backup survival signal. What result would best support further study?

Two last questions

These are not scored and are not added to your score. They are about how sure you feel, which is a different thing from what you know.

How confident are you that you can explain how normal development and cancer use some of the same cell processes?
How confident are you that you can use evidence to decide what a cancer treatment is designed to target?
You will get your score and the reasoning for every question.The two confidence questions are optional.